SARAH SUMNER: Open Payments
NPI 1205398914 · CAIRO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$531 in 28 payments from 13 companies in 2025. Trend: 2023 $270 · 2024 $336 · 2025 $531
Food & beverage: $531
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $103 |
| Novo Nordisk Inc | 4 | $78 |
| ABBVIE INC. | 3 | $60 |
| PFIZER INC. | 3 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Exact Sciences Corporation | 2 | $31 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| CSL Behring | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
Products named: AIRSUPRA, Ozempic, VRAYLAR, Kerendia, TRELEGY ELLIPTA, ELIQUIS, Cologuard Collection Kit, INSPIRE.
Industry payments across GA — which companies pay providers there.
